Trial Profile
Exebryl-1 for the treatment of Alzheimer′s disease.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 15 Jan 2010
Price :
$35
*
At a glance
- Drugs PTI 80 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors ProteoTech
- 13 Aug 2008 New trial record.